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Summary.-Electron spin resonance (ESR) spectroscopy was used to examine
changes in the concentrations of paramagnetic metal ions in Yoshida tumours carried
by female Wistar rats. Blood, spleen and lymph nodes from these animals were also
examined by ESR. A decrease in the concentration of a paramagnetic species
associated with mitochondrial activity, and marked increases in those thought to be
associated with inflammatory or immune reactions and cell lysis, were observed in
the tumours within one day of implantation. During development of the tumour,
and during its regression after treatment with methylene dimethane sulphonate
(MDMS), further changes were observed in the concentrations of the species. These
were dependent on the region of the tumour examined. In blood, development of the
tumour produced an increase in ceruloplasmin and a decrease in iron-transferrin.
An increase in spleen weight, as the tumour developed, was accompanied by a small
decrease in the concentration of species with g-values of 6-0 and 4-3, which was
reversed on regression of the treated tumour. The presence of metastases in the
regional lymph nodes produced readily distinguishable changes in their ESR spectra.
THE ESR technique has been used to
compare the paramagnetic metal ion con-
tent of frozen samples of normal and
malignant tissues (Nebert and Mason,
1963; V'ithayathil, Ternberg and
Commoner, 1965; Brennan, Cole and
Singley, 1966, Slater and Cook, 1969;
Emanuel et al., 1969; Duchesne and van de
Vorst, 1970; Swartz et al., 1973; Dodd,
1975) and also blood from normal and
tumour bearing patients (Swartz and
Wiesner, 1972; Foster et al., 1973; Mailer
et al., 1974). Although there appear to be
no ESR signals that are specific for
malignant tissue, certain signals show
quantitative differences. This paper re-
ports the sequential changes occurring
in the concentrations of the paramagnetic
metal ions in frozen tissue samples taken
from rats carrying a Yoshida tumour.
The work was undertaken in conjunction
with a study of the ascorbyl radical in
fresh tissue (Silcock and Dodd, 1976).
MATERIALS AND METHODS
A Yoshida tumour wNas carried by outbred,
female Wistar rats of 200-250 g body wt.
This tumour is sensitive to methylene
dimethane sulphonate (MDMS). The trans-
plantation of the tumour, its heterogenous
nature, histology and division by eye into
viable and degenerating regions are described
in Part I (Silcock and Dodd, 1976). During
development of the Yoshida tumour, blood
from approximately 10 rats, spleens from
6-8 and tumours from 4-6 rats were examined
daily. After injection with MDMS, blood
from approximately 6 animals and spleens
and tumours from 4-6 were examined daily.
The methods employed to obtain tissue
samples and to record their ESR spectra at
-196° have been described previously (Dodd,
1975). Signal heights wtere measured relative
to that of a standard manganese sample.
RESULTS
ESR 8ignals of the tumour
The ESR spectrum of tumour tissueESR OF TUMOURS. II
FIG. 1. ESR spectrum of the viable region of an implanted Yoshida tumour, after 7 days growth,
recorded at - 196°C. (A) Tumour spectrum recorded at 5 mW power, 10 gauss modulation,
1-25 x 103 gain. (B) Background spectrum recorded under identical conditions to (A). (C) The g 2
region of the tumour spectrum recorded at I gauss moduilationl, 5 x 103 gain.
(Fig. 1) differs markedly from that of the
normal surrounding muscle. The latter
shows 2 major components with approxi-
mate g-values of 2-00 and 1-94, whilst
spectra of tumour samples show many
components that vary in magnitude with
the stage of development of the tumour
and the region examined. The tumour
spectra show 2 low-field components, a
signal at g , 6 from Fe(1JJ) haem com-
pound, possibly methaemoglobin or met-
myoglobin and a 3-line signal at g , 4-3
from rhombic high-spin Fe(1JJ) probably
in iron-transferrin. The g 2 region
consists of several overlapping signals.
At low modulation amplitude (1 gauss), a
feature of many tumour samples is a
1: 1: 1 triplet signal with a g-value of
2*01 and hyperfine splitting of 16-17
gauss (Dodd, 1973). This can be assigned
to a NO-Fe(IJ) haemoprotein complex
(Maruyama et al., 1971). In certain
tumour samples an additional small triplet
signal is detectable at g 2-04, with a
hyperfine splitting of 15 gauss. The
higher and lower-field triplets are the
parallel and perpendicular components
respectively of the same spectrum (Bren-
nan, et al., 1966). This signal is super-
imposed on a very broad signal which is
more readily observed at higher modu-
lation amplitude (10 gauss). Power satu-
ration studies show the presence ofat least
3 different components: a narrow signal at
g - 2f005 that readily saturates and can
be assigned to free radicals, a signal with
g 2*04 and line width of approximately
40 gauss, and a signal with g 2*03 and a
line width of about 130 gauss. The 2
latter signals do not readily saturate and
are possibly due to copper or iron com-
plexes. Quantitation of the g 2-04
peak is complicated by the presence ofthe
underlying broad peak and the narrow
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FIG. 2.-Changes in the relative heights of ESR signals in implanted Yoshida tumours, during their
development. The vertical lines denote standard errors. Signals: (a) g 6; (b) g 4-3; (c) g 2-03
(broad g 2); (d) g 2-01 (triplet) and (e) g 1*94. Key: * original implant; 0 viable tissue;
x degenerating tissue.
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NO-haemoprotein signal. Therefore,
measurement has here been confined to the
broad g .- 2-03 peak. At higher magnetic
fields, a component with a g-value of 1P94,
attributable to a mitochondrial, sulphur-
containing, non-haem iron complex (Hol-
locher, Solomon and Ragland, 1966;
Mallard and Kent, 1969) is also detectable.
The probable assignments of the ESR
signals that have been measured in
samples of the Yoshida tumour, are
summarized in the Table.
TABLE A Summary of the Measured ESR
Signals, with Probable Assignments, in
Samples of Yoshida Tumours
Signal
(Approx. g-value) Assignment
6 High-spin Fe(III) complex,
possibly methaemoglobin or
metmyoglobirn.
4.3 Rhombic high-spin Fe(III) com-
plex, probably iron-transferrin.
2-03 (broa(d g 2) Possibly a Cu(lI) or Fe(III)
complex.
2 01 (triplet) NO-Fe(II) haemoprotein com-
plex.
1-94 Mitochondrial S-containing non-
haem iron complex.
ESR changes in the untreated tumour
The implanted tissue was taken from
the viable region of a 7-day-old tumour.
On Days 1-3 after implantation, the whole
of the implant was sampled, but by Day 4
new viable tissue was detectable around
the implant. At this stage the original
transplant could still be distinguished and
was degenerating. Therefore, from Day
4, the 2 regions of the tumour were
sampled separately. The changes with
time after implantation in the relative
heights of the ESR signals with g-values
of 6-0, 4 3, 2-03 (broad g -, 2 signal),
2*01 (triplet signal) and 1-94 in the
original implant, the viable and degene-
rating regions of the tumour are shown in
Fig. 2. Within one day of implantation
the original implant showed a marked
increase in the signals at g-values of 6 and
4.3 (a, b), the broad g 2-0 (c) signal and
the triplet signal (d) and a decrease in the
signal at g -, 1 94 (e). The g 6, the
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broad g -' 2O0 and the triplet signals then
fell by Day 3 to their original levels or
lower. The g - 4-3 signal showed a
slight decrease by Day 3 but, as the
tumour developed, the signal from the
degenerating region remained generally
high, and that in the viable region fell.
The g '-' 1-94 (e) signal showed the reverse
effect, the signal from the degenerating
region remaining low, while that from the
viable tissue gradually rose to the level
found in normal muscle.
As the tumour developed, the g
- 6 (a)
signal increased to a maximum in the
degenerating region on Days 8 and 9 and
then fell. A small change occurred in the
viable region. The broad g '2
-0 signal
(c) was similar in viable and degenerating
regions between Days 4 and 7. On Day 8
it appeared to be elevated in the degene-
rating region, but then between Days 9
and 14 decayed slightly in the degene-
rating region and more markedly in the
viable region. The triplet signal (d), on
the other hand, showed a greater change
in the viable tissue, rising to a maximum
on about Day 5 and then falling below
that in the degenerating region in the
later stages of tumour development.
The implanted tumourwas surrounded,
at all stages of its development, by an
inflammatory exudate. The major fea-
tures of its ESR spectrum were signals at
g-values of 4-3 and 2 05, which were
assigned to the serum proteins iron-
transferrin and ceruloplasmin. The spec-
trum showed minor signals at g-values of
200, 1P97 and 1-94.
ESR changes in the treated tunmotr
Treatment oftumour-bearing rats with
MDMS on Day 7 produced regression of
the tumour (Fox, 1969) and by Day 14
(7 days after treatment) the weight of the
tumour was 0-I g or less. The response
of the tumour to MDMS, as measured by
ESR, was generally greater in the initially
viable, peripheral region than in the
already degenerating, central region (Fig.
3a-e). The g 6 signal, the broad g
2-0 signal and the triplet signal increased
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Fio(. 4.- Changes in the relative heights of
ESIR siginals in blood, (luIring the (develop)-
menit of the Yoshi(la tuLmourl The vertical
lines (lenote stani(lar(l errors.
initiallv in both regions and then fell as the
tumour regressed. The g 4-3 signal
showed a continual increase, which was
more marked in the peripheral region, and
the g 1-94 signal decayed in the peri-
pheral region, while remaining relativelyr
constanit in the central region.
Bloodl
The two major components of the
lspectrum of frozen rat blood are peaks at
g-values of 4-3 and 2-05, due to iron-
transferrin anid ceruloplasmin respectively
(Dodd, 1975). Changes in the relative
signal height of these 2 components, with
time after implantation of the tumour,
are shown in Fig. 4. No change was
letectable for the first 4 days. The
ceruloplasmin signal increased to a maxi-
Relative Signal Height
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Fi(c. 5. Changes in the relative heights of
ESR signals in blood of tumour-bearing
animals after injection with AIDMS. The
vertical lines (lenote standard errors anct
the arrow at Day 7 the injection with
DIDMIS. The (lottecl line iindicates the
changes in. the g , 2-05 (ceruloplasmin)
signal in blood of tuntreated tumour-
bearing animals and the brokein line those
in the g , 4.3 (iron-transferrin) siginal.
mum on about Day 6, remained steady
until Day 10 and then, in the final stages
of the disease, fell towards its value prior
to implantation of the tumour. The
iron-transferrin signal mirrored these
changes, falling to a minimum on Day 5
or 6, remaining at that level until Day 10
or 11, before rising again.
After treatment with MDMS there was
a rapid rise in the levels ofiron-transferrin
and ceruloplasmin, which fell again within
4 days of injection (Fig. 5). A similar
change was also observed when healthy
Fic(. 3. Changes in the relative heights of ESR signals in implantcd Yoshi(da tumours, after iinjection
oftheanimals with MDMS on Dav 7. The vertical lines (le)note stand(iar( errors aid the arrow at Day
7 the injectioin -with AIDMS. Signals: (a) g 6; (b) g 4-3; (c) g 2-03 (broad g 2);
(d) g 2-01 (triplet) anid (e) g , 1]94. Key: *0 viable tissue, at time oftreatment; x (legenerating
tissute, at time of treatment. The (lotte(i linies indticate the changes in the signals of the viable tissue
of an untreated ttumouir, and the broken lines, those of the (legeneiatiilg tissue.
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Fie. 6.--Changes in the relative heights of
ESR signals in spleen, during the develop-
ment of the Yoshidatumour. The vertical
lines denote standard errors.
rats were injected with MDMS. As the
tumour regressed, iron-transferrin and
ceruloplasmin returned slowly to the levels
in untreated animals.
Spleen
Due to the increase in spleen weight
observed during the development of the
Yoshida tumour (Silcock and Dodd, 1976),
this organ was examined by ESR. The
spectrum ofnormal rat spleen is similar to
that ofthe mouse (Dodd, 1975). It shows
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FIG 7. Changes in the relative heights of
ESR signals in spleen of tumour-bearing
animals, after treatment with MDMS. The
vertical lines denote standard errors and
the arrow at Day 7 the injection with
MDMS. The dotted line indicates the
changes in the g 4-3 signal in spleen of
untreated tumour-bearing animals and the
broken line those in the g 6 signal.
5 major components with approximate
g-values of 6-0, 4 3, 2-04, 200 and 1*94.
These signals are attributed to a high spin
Fe(I11) haem complex, a rhombic high
spin Fe(111) complex, different from that
in tumour tissue, a copper complex, a
mitochondrial flavin semiquinone and a
mitochondrial, sulphur-containing, non-
haem iron complex, respectively (see
Dodd, 1975 for references). During the
development of the tumour, the signals at
g-values of 1P94, 2O00 and 2-04 showed no
significant change with time. Changes in
the signals at g 4*3 and g 6 are shown
in Fig. 6. The g , 4-3 signal decreased
from approximately Day 5 onwards, while
the g 6 signal appeared to rise on Day 1
and then decayed to a barely detectable
level by Day 14.
Treatment ofthe Yoshida-bearing rats,
on Day 7 of the disease, with MDMS
maintained the g . 4-3 and g ' 6 signals
during the period 7-14 days at the values
prior to implantation of the tumour (Fig.
7). The g 2-04 signal showed a 3-fold
increase on Day 9 of the disease (the 2nd
day after treatment) returning to normal
by Day 12. This change was not observed
in the spleens ofhealthy rats injected with
MDMS. The signals at g-values of 200
and 1-94 in the spleens of tumour-bearing
rats appeared to be unaffected by MDMS
treatment.
Lymph nodes
From Day 9 onwards, metastases were
visible in the lymph nodes with increasing
frequency, particularly in the inguinal and
axillary nodes. The ESR spectra of
normal and invaded nodes were examined.
Normal lymph nodes showed 3 major
components at g-values of 4 3, 200 and
1'94. These showed little saturation at
higher microwave powers. On metastasis,
the signal at g 4 3 decreased markedly,
a broad signal at g 2 appeared, and in
some cases a 1 1: 1 triplet could be
detected. The spectrum then closely
resembled that of the viable tissue of the
tumour. After treatment with MDMS
the metastases resolved and the ESR
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spectrum of the lymph nodes returned to
normal. The early stages of regression
were marked by the appearance of a large
signal at g 6.
DISCUSSION
Tumour
The changes occurring in ESR spectra
of tumour tissue can be related to the
development of the implant. The magni-
tude of the g 1-94 signal, which is
believed to be mitochondrial in origin
(Nebert and Mason, 1963), may indicate
the growth or survival of the tumour
tissue. In the initial implant, many of
the cells die and the g 1-94 signal
decreases. The surrounding inflamma-
tory exudate, which contains very few cells
shows only a small g 1-94 signal. In
the more necrotic region ofthe developing
tumour, the g P194 signal remains low,
whilst in the active viable region, this
signal approaches or surpasses that in the
surrounding normal muscle. Treatment
with MDMS produces extensive necrosis
in the viable tissue and this is reflected in a
fall in the magnitude of the g 1-94
signal, in this tissue, to the level in the
previously degenerating tissue.
An increase in the g , 6 signal prob-
ably indicates conversion of Fe(II) to
Fe(III) in haem complexes. An increase
in this signal is seen shortly after implanta-
tion of the tumour tissue. Subsequently,
the degenerating regions of the growing
tumour show a marked increase in the
g , 6 signal, while the viable regions show
a smaller effect. During the generalized
cell breakdown after MDMS treatment,
previously viable and degenerating regions
show an increase in the magnitude of the
g , 6 signal. These changes are very
similar to those of the ascorbyl radical
observed in fresh tumour tissue (Silcock
and Dodd, 1976). A relationship between
the appearance ofthe ascorbyl radical and
immunological reactions, capable of pro-
ducing cell lysis, has been postulated.
The increase in the g 6 signal may
result from the same reactions.
The triplet signal is observed following
protein denaturation and formation of
NO (Maruyama et al., 1971) and
therefore indicates cellular deterioration.
Since, in contrast to the g - 6 signal, a
larger triplet signal is seen in the generally
viable region of the developing tumour
than in the overtly degenerating region,
the formation ofNO-Fe(II) haemoproteins
may occur at an earlier stage of degenera-
tion than the formation of Fe(111) haemo-
proteins.
The g ' 4-3 signal in tumour tissue is
believed to be due to iron-transferrin, as
in blood, and may be indicative of the
presence of serum due to an inflammatory
response. This response appears to be
maintained in the degenerating region,
while in the more viable region the signal
falls, possibly indicating suppression ofthe
response. MDMS treatment will have a
greater effect on viable than on degene-
rating cells and this is reflected in the
greater increase of the g -, 4-3 signal in
the viable regions of the tumour.
Changes in the broad g , 2 signal are
partially masked by those ofother signals,
and further work is required to separate
the contributions of individual compo-
nents. There is probably some contri-
bution from the g , 2-05 signal of cerulo-
plasmin. This would be expected to
accompany the increase in iron-transferrin
in the inflammatory response. The pre-
sence of serum in the inflammatory
exudate is reflected in the ESR spectrum,
which shows both iron-transferrin and
ceruloplasmin signals as major compo-
nents. However, in the tumour, changes
in the iron-transferrin signal are not
paralleled by those in the broad g , 2
signal. This, like the g 6 signal, is
probably associated with cellular degenera-
tion.
Blood
The changes observed in the spectrum
of blood from Yoshida-bearing rats give
an indication ofthe stage ofthe disease and
differ markedly from those observed with
blood from leukaemic mice (Dodd, 1975).
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Ceruloplasmin and iron-transferrin remain
constant until vascularization of the
tumour implant. They then change in
opposite directions. The decrease in iron-
transferrin may result from a demand for
iron by the tumour, and the increase
in ceruloplasmin may be an attempt to
restore the level ofiron in the blood. The
initial increase in iron-transferrin in the
tumour implant appears to be insufficient
to influence the level detectable in the
blood. In the phase of generalized dis-
ease, when metastases are present, iron-
transferrin increases and ceruloplasmin
decreases. This probably reflects a break-
down in normal metabolism. In control
experiments, it was shown that the changes
in blood shortly after injection of MDMS
are independent of the presence of the
tumour. However, subsequent regres-
sion is marked by a return of the cerulo-
plasmin and iron-transferrin levels to
normal.
Spleen
The g 43 signal in spleen represents
a species different from that in tumour
tissue. Its steady decrease may indicate
loss of iron from the spleen to the develop-
ing tumour. The ascorbyl radical coIn-
centration of spleen tends to decrease
(Silcock and Dodd, 1976), but the magni-
tude ofthe decrease is smaller than that of
the g , 6 signal.
Lymph nodes
Since the ESR spectra oflymph nodes,
in the later stages of the disease, closely
resemble those of the viable region of the
tumour, they demonstrate the presence of
malignant cells. The iron-transferrin sig-
nal of the nodes is reduced on invasion,
but is restored after regression of the
metastases. However, a change of cell
type in the node does not affect the g
1-94 signal, suggesting that the overall
mitochondrial activity is unaltered. The
sudden increase in the g
- 6 signal,
following MDMS treatment, is probablv
due to destruction oftumour cells resulting
in release of haem iron in the ferric form,
as is observed in the tumour, although not
reflected in the blood.
CONCLUSION
Detailed examination of some tissues
associated with developing and regressing
Yoshida tumouirs, by means of ESR,
shows distinct changes in the metabolism
of these tissues. These can act as a guide
to the stage of the disease, although their
exact nature is still unclear. Some may
be involved in iron transport, as postulated
for tissues of leukaemic mice, and/or
immunological or general inflammatory
reactions. The interrelationship of these
changes is complex and appears to be
different for different tissues. This mav
be a function ofthe site of malignancy and
the nature ofthe involvement ofparticular
tissues.
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